A Randomized Phase II Study of Pemetrexed or RAD001 as Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients: Treatment Rationale and Protocol Dynamics
Authors:
- Cesare GridelliCGCesare Gridelli
- Antonio RossiARAntonio Rossi
- Floriana MorgilloFMFloriana Morgillo
- Maria Anna BareschinoMBMaria Anna Bareschino
- Paolo MaionePMPaolo Maione
- Massimo Di MaioMassimo Di Maio
- Fortunato CiardielloFCFortunato Ciardiello
- 1 November 2007
- journal article
- research article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 8 (9) , 568-571
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Chemotherapy for Elderly Patients With Non-Small Cell Lung CancerChest, 2005
- Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert PanelJournal of Clinical Oncology, 2005
- Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With ChemotherapyJournal of Clinical Oncology, 2004
- American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003Journal of Clinical Oncology, 2004
- Participation of Patients 65 Years of Age or Older in Cancer Clinical TrialsJournal of Clinical Oncology, 2003
- Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized TrialJNCI: Journal of the National Cancer Institute, 2003
- Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy RegimensJournal of Clinical Oncology, 2000
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyJournal of Clinical Oncology, 2000
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsNew England Journal of Medicine, 1999
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 1999